CJC-1295 - Third-Party Test Results

Manufacturer: LeoLab™

Sample: CJC-1295

Date: 25 MAR 2025

LeoLab continues to reinforce its reputation for delivering premium-quality peptides with the recent third-party testing results of their CJC-1295 peptide. Independent analysis was conducted by the respected laboratory Janoshik Analytical, providing customers with transparent and reliable data regarding the product’s quality and composition.

Test Summary

  • Testing Authority: Janoshik Analytical

  • Task Number: 60436

  • Sample Tested: CJC-1295

  • Batch Number: G60098

  • Date of Analysis: 25 March 2025

  • Purity: 99.114%

  • Sample Mass: 4.75 mg

🧪 Analysis and Findings

The tested CJC-1295 sample demonstrated exceptional purity at 99.114%, a level that exceeds industry standards for research-grade peptides. This high purity confirms that the product is virtually free from unwanted byproducts, contaminants, or synthesis-related impurities, making it a trustworthy option for advanced research or personal study.

The total sample mass of 4.75 mg aligns well with label claims, indicating accurate formulation and careful batch control by LeoLab’s production team.

Purity 99.114%

The CJC-1295 batch (G60098) from LeoLab was independently tested by Janoshik Analytical on 25 March 2025, confirming an exceptional purity of 99.114%. This result highlights the high-quality synthesis and minimal presence of impurities, ensuring reliable and consistent performance for research use.

Mass 4.75 mg

The CJC-1295 sample from batch G60098 was confirmed by Janoshik Analytical to have a mass of 4.75 mg. This precise measurement verifies accurate dosing and consistency with product specifications, ensuring reliability for research applications.

Leave a Reply